MPM BioImpact reported a 6.2% stake in Compass Therapeutics CMPX · 8,567,896 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 6.2%
Last report: First report
Shares held: 8,567,896 sh
Class: Common Stock, par value $0.001 per share
Stock: Compass Therapeutics CMPX
Holder: MPM BioImpact
Event date: 24/12/31
Filed: 25/02/14

First 5%+ report · 6.2% stake

Compass Therapeutics trades, last 26 weeks

What else happened in Compass Therapeutics around then

Filed or reported within 30 days of the trade day · 24/12/01~25/01/30

MPM BioImpact's other 5% stake reports

MPM BioImpact
5% stakeContext Therapeutics
5% stake
Context Therapeutics
CNTX
1.4% stake
1,299,046 sh
1.4% stake
Filed 08/14
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
6.2% stake
18,331,420 sh
6.2% stake
Filed 08/14
MPM BioImpact
5% stakeClimb Bio
5% stake
Climb Bio
CLYM
0% stake
0 sh
0% stake
Filed 08/14
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
8.8% stake
26,066,806 sh
8.8% stake
Filed 05/15
MPM BioImpact
5% stakeDBV Technologies
5% stake
DBV Technologies
DBVT
9.9% stake
24,579,307 sh
9.9% stake
Filed 02/17